Ductal carcinoma in situ tied to threefold higher risk for death

Ductal carcinoma in situ tied to threefold higher risk for death

(HealthDay)—There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online Sept. 16 in JAMA Network Open.

Vasily Giannakeas, M.P.H., from University of Toronto, and colleagues used the Surveillance, Epidemiology and End Results (SEER) database to identify 144,524 women who had a first primary DCIS diagnosis between 1995 and 2014. Women were followed through March 2020 to identify risk for dying of .

The researchers found 1,540 deaths from breast cancer in the cohort. Using the SEER-based incidence and case-fatality rates, 458 breast cancer deaths would have been expected in the general population. Among with DCIS, the standardized mortality ratio for death from breast cancer was 3.36. More than 15 years after diagnosis, the elevated risk for death persisted.

"This suggests that our current treatment focus on preventing invasive recurrence is insufficient to eliminate all deaths from breast cancer after DCIS," the authors write.


Explore further

Study sheds light on risks of breast cancer after pre-invasive disease

More information: Abstract/Full Text
Journal information: JAMA Network Open

Copyright © 2020 HealthDay. All rights reserved.

Citation: Ductal carcinoma in situ tied to threefold higher risk for death (2020, October 2) retrieved 1 December 2020 from https://medicalxpress.com/news/2020-10-ductal-carcinoma-situ-tied-threefold.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments